Skip to main content
. 2022 Nov 28;19(11):811–821. doi: 10.11909/j.issn.1671-5411.2022.11.009

Table 4. Variable analysis of factors that may influence inflammatory markers post TAVR for patients ≥ 80 years.

WBC at 24 h Abs. neutrophils at 24 h Abs. lymphocytes at 24 h NL ratio at 24 h
(Median [IQR]) P-value (Median [IQR]) P-value (Median [IQR]) P-value (Median [IQR]) P-value
Data are presents as median (interquartile range). Continues variables between the various study groups were tested for normality by Shapiro-Wilk test and when abnormal distribution was found Mann-Whitney test was performed, when the distribution was normal t - test was used. *Correlation between two Continues variables was tested by Pearson Correlation. Abs: absolute; AI: aortic insufficiency; AV: aortic valve; AVA: aortic valve area; BEV: balloon expandable valve; CABG: coronary artery bypass grafting; LVEF: left ventricle ejection fraction; NL: neutrophils to lymphocytes; STS: Society of Thoracic Surgeons; SEV: self-expandable valve; TAVR: transcatheter aortic valve replacement; WBC: white blood cells.
Gender Females 9.53 (7.69-11.8) 0.637 7.8 (5.7-9.67) 0.453 1 (0.7-1.4) 0.385 7.12 (4.78-11.33) 0.756
Males 9.2 (7.6-11.5) 7 (5.7-10) 0.99 (0.7-1.3) 7.22 (5.15-12.66)
Age*, yrs 0.018 0.750 −0.050 0.932 0.035 0.525 −0.023 0.680
Body mass index*, kg/m2 0.087 0.174 0.053 0.413 0.127 0.047 −0.070 0.275
HTN No 9.6 (6.8-15.3) 0.702 7.9 (4.9-12.5) 0.567 0.9 (0.7-1.2) 0.430 8.77 (5.56-15.62) 0.271
Yes 9.4 (7.7-11.6) 7.4 (5.7-9.6) 1 (0.7-1.3) 7.21 (4.9-11.37)
Diabetes No 9.5 (7.7-12.22) 0.216 7.7 (5.824-10.27) 0.133 0.9 (0.7-1.3) 0.076 8 (5.2-12.83) 0.013
Yes 9.1 (7.5-11.3) 7 (5.5-9.1) 1.1 (0.79-1.4) 6.72 (4.66-9.344)
Dyslipemia No 9.25 (7.62-13.4) 0.665 7.85 (5.72-10.6) 0.375 0.9 (0.71-1.2) 0.333 8.07 (5.18-12.2) 0.144
Yes 9.4 (7.65-11.55) 7.4 (5.7-9.48) 1 (0.7-1.4) 6.97 (4.87-11.28)
Smoker No 9.4 (7.69-11.8) 0.802 7.43 (5.7-9.79) 0.757 1 (0.7-1.33) 0.938 7.21 (4.9-11.85) 0.909
Yes 9.61 (7.6-11.4) 7.445 (5.9-9.51) 1.1 (0.6-1.3) 7.77 (5.26-10.83)
A. fibrillation No 9.5 (7.62-12) 0.375 7.505 (5.7-10.2) 0.209 1 (0.7-1.3) 0.835 7.65 (5-12) 0.293
Yes 9.2 (7.5-11.1) 7 (5.4-9.0415) 1 (0.7-1.4) 6.8 (4.78-11.33)
CAD No 9.39 (7.5-11.7) 0.743 7.4 (5.7-9.79) 0.916 0.99 (0.7-1.3) 0.544 7.18 (4.9-11.8) 0.993
Yes 9.6 (7.8-11.6) 7.4 (5.8-9.4) 1 (0.7-1.315) 7.45 (4.97-11.46)
PVD No 9.4 (7.61-11.7) 0.860 7.49 (5.7-9.795) 0.712 1 (0.7-1.33) 0.932 7.17 (4.86-12.14) 0.865
Yes 9.39 (7.8-11.65) 6.995 (5.8-9.5) 1 (0.76-1.2542) 7.66 (5.64-10.05)
S/P MI No 9.4 (7.6-11.7) 0.836 7.43 (5.7-9.7) 0.741 1 (0.7-1.315) 0.821 7.14 (4.95-11.78) 0.832
Yes 9.53 (7.7-11.4) 7.2 (5.9-9.3) 1 (0.8-1.3) 7.85 (5.02-11.34)
S/P CVA-TIA No 9.345 (7.6-11.68) 0.280 7.355 (5.7-9.67) 0.270 1 (0.7-1.4) 0.228 7.18 (4.86-11.57) 0.196
Yes 9.9 (8.4-12.1) 7.9 (6.5-11) 1 (0.7-1.2) 7.86 (5.75-12.14)
Pacemaker No 9.4 (7.7-11.9) 0.355 7.415 (5.8-10) 0.288 1 (0.7-1.355) 0.555 7.19 (4.89-12.07) 0.777
Yes 9.41 (7.4-10.75) 7.12 (5.2-9.1) 0.9 (0.7-1.2) 7.4 (5.37-10.43)
S/P CABG No 9.3 (7.59-11.5) 0.645 7.1 (5.5-9.51) 0.531 1.03 (0.7-1.33) 0.733 6.72 (4.76-11.16) 0.466
Yes 9.695 (8.4-11.7) 7.315 (6.75-9.85) 0.9198 (0.665-1.29) 8.06 (5.79-10.07)
STS score* 0.234 0.323 0.412 0.52 0.214 0.71 0.165 0.568
Baselines Echo
*LVEF (%) 0.094 0.095 0.077 0.170 0.090 0.110 −0.040 0.485
*AVA, cm2 −0.052 0.377 −0.070 0.239 0.107 0.073 −0.113 0.057
*AV gradient mean, mmHg 0.041 0.640 0.037 0.694 −0.058 0.509 0.056 0.524
*Septum thickness, mm 0.103 0.067 0.091 0.107 −0.029 0.606 0.080 0.161
SEV vs. BEV SEV 9.79 (7.8-12.1) 0.040 7.74 (5.9-10.2) 0.046 1 (0.7-1.3) 0.417 7.65 (5-12.2) 0.094
BEV 9.1 (7.1-11.1) 7.1 (5.4-9.4) 1 (0.71-1.4) 6.83 (4.78-10.44)
*Contrast volume, mL 0.152 0.006 0.174 0.002 −0.038 0.490 0.109 0.051
*Time, min 0.145 0.009 0.213 < 0.001 −0.209 < 0.001 0.263 < 0.001
Post dilatation No 9.4 (7.6-11.7) 0.577 7.31 (5.7-9.7) 0.419 1 (0.76-1.4) 0.085 7.06 (4.87-11.35) 0.159
Yes 9.65 (7.66-11.9) 8 (5.995-9.995) 0.9396 (0.6-1.2) 8.03 (5.18-12.57)